back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-10-05 18:13 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-300,000
-60,000 vol $5.00 each |
0 | |
| Filed 2022-10-05 18:12 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$96,101
+68,157 vol $1.41 each |
68,157 | |
| Filed 2022-10-05 18:10 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-10-14 11:55 Tx date 2021-10-12 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: 838447 Ontario Inc. (Indirect Ownership)
|
Common Shares (Class A)
54 - Exercise of warrants
|
$65,000
+20,000 vol $3.25 each |
460,000 | |
| Filed 2021-10-14 11:51 Tx date 2021-10-12 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: 838447 Ontario Inc. (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-65,000
-20,000 vol $3.25 each |
0 | |
| Filed 2020-06-05 17:27 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: 838447 Ontario Inc. (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$4,400
+20,000 vol $0.22 each |
20,000 | |
| Filed 2020-06-05 17:23 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: 838447 Ontario Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-05 17:22 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: 838447 Ontario Inc. (Indirect Ownership)
|
Common Shares (Class A)
15 - Acquisition or disposition under a prospectus
|
$95,600
+40,000 vol $2.39 each |
440,000 | |
| Filed 2019-10-18 13:54 Tx date 2019-10-17 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$10,753
+3,090 vol $3.48 each |
3,090 | |
| Filed 2019-10-18 13:52 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-02-06 Tx date 2019-02-04 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: Natalie Lazarowych RRSP (Control or Direction)
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$10,010
+1,400 vol $7.15 each |
1,400 | |
| Filed 2019-02-06 Tx date 2019-02-04 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: Peter Pekos RRSP (Indirect Ownership)
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$19,950
+2,800 vol $7.13 each |
2,800 | |
| Filed 2019-02-06 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: Natalie Lazarowych RRSP (Control or Direction)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-02-06 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: Peter Pekos RRSP (Indirect Ownership)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-24 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: 838447 Ontario Inc. (Control or Direction)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
| Filed 2018-12-21 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
60,000 |